EDGAR Filing Documents for 0001100412-15-000018

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001100412-15-000018

Filing Date

2015-05-07

Accepted

2015-05-06 21:50:48

Documents

Period of Report

2015-03-31

Document Format Files

Seq	Description	Document	Type	Size
1	10-Q	a3311510-q.htm	10-Q	1209726
2	EXHIBIT 10.1	ex101.htm	EX-10.1	412139
3	EXHIBIT 10.2	ex102.htm	EX-10.2	78056
4	EXHIBIT 10.3	ex103.htm	EX-10.3	37970
5	EXHIBIT 10.4	ex104.htm	EX-10.4	153800
6	EXHIBIT 10.5	ex105.htm	EX-10.5	183904
7	EXHIBIT 31.1	ex31133115.htm	EX-31.1	14686
8	EXHIBIT 31.2	ex31233115.htm	EX-31.2	13951
9	EXHIBIT 32.1	ex32133115.htm	EX-32.1	11680
	Complete submission text file	0001100412-15-000018.txt		9902960

Data Files

Seq	Description	Document	Type	Size
10	XBRL INSTANCE DOCUMENT	arry-20150331.xml	EX-101.INS	1410078
11	XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT	arry-20150331.xsd	EX-101.SCH	49067
12	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT	arry-20150331_cal.xml	EX-101.CAL	66228
13	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT	arry-20150331_def.xml	EX-101.DEF	251562
14	XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT	arry-20150331_lab.xml	EX-101.LAB	698594
15	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT	arry-20150331_pre.xml	EX-101.PRE	404535

Mailing Address 3200 WALNUT STREET BOULDER CO 80301

Business Address 3200 WALNUT STREET BOULDER CO 80301 3033816600

ARRAY BIOPHARMA INC (Filer) CIK: 0001100412 (see all company filings)